Neurana Pharmaceuticals
Ms. Simões has 10 years of experience in the biotech industry and is responsible for leading Neurana’s corporate development activities, including business development, commercial strategy, and investor relations. Prior to Neurana, Ms. Simões was head of corporate development at Anthera Pharmaceuticals (Nasdaq: ANTH). Ms. Simões started her career in business development at Trius Therapeutics (Nasdaq: TSRX) where she had increasing roles of responsibility, culminating in her group leading a $700M+ acquisition by Cubist Pharmaceuticals.
Ms. Simões holds a B.S. in Business Administration from Bucknell University.
This person is not in any teams
This person is not in any offices
Neurana Pharmaceuticals
Neurana Pharmaceuticals is a privately-held clinical-stage San Diego-based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders.